Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal-Reference-Cited by-同舟云学术

Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal

Published:2006-07 Issue:2 Volume:134 Page:227-232
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Legnani Cristina,Mattarozzi Silvia,Cini Michela,Cosmi Benilde,Favaretto Elisabetta,Palareti Gualtiero

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06130.x/fullpdf

Reference19 articles.

1. RELEVANCE OF PREOPERATIVE AND POSTOPERATIVE BLOOD TESTS TO POSTOPERATIVE LEG-VEIN THROMBOSIS

2. Short Activated Partial Thromboplastin Times Are Related to Increased Thrombin Generation and an Increased Risk for Thromboembolism

3. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

4. High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The dos, don'ts, and nuances of thrombophilia testing;Hematology;2023-12-08

2. Role of factor VIII, IX, and XI in venous thrombosis recurrence risk in adults and children: A systematic review;Research and Practice in Thrombosis and Haemostasis;2023-02

3. Reference values of coagulation assays performed for thrombophilia screening after a first venous thrombosis and their intra-patient associations;Thrombosis Research;2022-02

4. Coeliac artery and splenic artery thrombosis complicated with splenic infarction 7 days following the first dose of Oxford vaccination, causal relationship or coincidence?;BMJ Case Reports;2021-07

5. The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease;Clinical Rheumatology;2021-06-16